Literature DB >> 7759893

Up-regulation of inducible cyclooxygenase gene expression by platelet-activating factor in activated rat alveolar macrophages.

M Thivierge1, M Rola-Pleszczynski.   

Abstract

Platelet-activating factor (PAF) can stimulate alveolar macrophages (AM) to produce IL-6 through a PG-dependent process. In this study, the modulation by PAF of the expression of COX-2, the inducible isoform of PG synthase, was investigated. Expression of COX-2 mRNA was increased in rat AM within 2 h after treatment with either of the bacterial products LPS or muramyl dipeptide (MDP) alone. Although PAF had no effect by itself, stimulation of AM with a combination of PAF (10(-10) to 10(-8) M) and LPS or MDP resulted in a synergistic, three- to fivefold increase in levels of COX-2 mRNA. No significant change was observed in the mRNA expression of the constitutive isoform, COX-1. The antagonist WEB 2170 blocked the action of PAF, whereas lyso-PAF was inactive on the COX-2 gene expression. The effect of PAF was rapid, being evident by 30 to 60 min of stimulation and was accompanied by enhanced production of PGE2. Two relatively selective inhibitors of COX-2 abolished the PAF-dependent increase in PGE2 production. Moreover, inhibition of transcription with actinomycin D completely abrogated the effect of PAF on both COX-2 mRNA and PGE2 production. These results suggest that COX-2 expression can be regulated at the transcriptional level by PAF, in synergy with bacterial products. PAF-dependent up-regulation of COX-2 expression may constitute a novel element in the interrelationship between PAF and prostanoids in the context of allergic, inflammatory, and immune processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759893

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage.

Authors:  G Herrero-Beaumont; J Egido
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

2.  Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation.

Authors:  Hong Li; J Alyce Bradbury; Ryan T Dackor; Matthew L Edin; Joan P Graves; Laura M DeGraff; Ping Ming Wang; Carl D Bortner; Shuichiro Maruoka; Fred B Lih; Donald N Cook; Kenneth B Tomer; Anton M Jetten; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

3.  Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes.

Authors:  W J Lukiw; R P Pelaez; J Martinez; N G Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Authors:  Salma Al-Darmaki; Kandi Knightshead; Yuichi Ishihara; Al Best; Harvey A Schenkein; John G Tew; Suzanne E Barbour
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

5.  Platelet-activating factor: a previously unrecognized mediator of fever.

Authors:  Andrei I Ivanov; Shreya Patel; Vladimir A Kulchitsky; Andrej A Romanovsky
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

6.  Differential usage of COX-1 and COX-2 in prostaglandin production by mast cells and basophils.

Authors:  Tomoyuki Bando; Setsuko Fujita; Naoko Nagano; Soichiro Yoshikawa; Yoshinori Yamanishi; Masashi Minami; Hajime Karasuyama
Journal:  Biochem Biophys Rep       Date:  2017-03-15

7.  Impaired immunomodulatory ability of type 2 diabetic adipose-derived mesenchymal stem cells in regulation of inflammatory condition in mixed leukocyte reaction.

Authors:  Sara Aliakbari; Mobin Mohammadi; Mohammad Ali Rezaee; Abbas Ali Amini; Shohreh Fakhari; Mohammad Reza Rahmani
Journal:  EXCLI J       Date:  2019-09-23       Impact factor: 4.068

8.  The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis.

Authors:  Ruoshuang Zhang; Zheli Liu; Han Zhang; Yi Zhang; Dong Lin
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

9.  Mechanisms and Treatment of Light-Induced Retinal Degeneration-Associated Inflammation: Insights from Biochemical Profiling of the Aqueous Humor.

Authors:  Dmitry V Chistyakov; Viktoriia E Baksheeva; Veronika V Tiulina; Sergei V Goriainov; Nadezhda V Azbukina; Olga S Gancharova; Eugene A Arifulin; Sergey V Komarov; Viktor V Chistyakov; Natalia K Tikhomirova; Andrey A Zamyatnin; Pavel P Philippov; Ivan I Senin; Marina G Sergeeva; Evgeni Yu Zernii
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.